Press release distribution, EDGAR filing, XBRL, regulatory filings


EUSA Pharma Receive Positive Opinion from The CHMP For tivozanib For The First-Line Treatment of Advanced Renal Cell Carcinoma In The European Union )--EUSA Pharma , a specialty pharmaceutical company with a focus on oncology and oncology supportive care, today announced that the European Medicines ... European CHMP Adopts Positive Opinion for Gilead's Vosevi for the Treatment of All Chronic Hepatitis C Genotypes )--Gilead Sciences, Inc. today announced that the Committee for Medicinal Products for Human Use , the scientific committee of the European M... )--The Honorable Arthur L. Money, former Assistant Defense Secretary for Command, Control, Communications and Intelligence, joined HawkEye 360's board.



from Biotech News